Format

Send to

Choose Destination
J Antimicrob Chemother. 2003 Jun;51(6):1365-71. Epub 2003 Apr 25.

The bacteriocin piscicolin 126 retains antilisterial activity in vivo.

Author information

1
CSIRO Livestock Industries, Private Bag 24, Geelong, Victoria 3220, Australia. aaron.ingham@csiro.au

Abstract

OBJECTIVE:

We have conducted a series of experiments to show that the bacteriocin piscicolin 126 (P126) retains antilisterial activity after injection into a mouse.

METHODS:

Groups of mice were challenged intravenously with Listeria monocytogenes and treated with purified P126 at varying times before and after challenge to determine whether administration of this peptide reduced numbers of colonizing L. monocytogenes and the symptoms of listeriosis.

RESULTS:

The bacteriocin P126 retained antilisterial activity after injection into the mouse. During the early time-points of listerial infection, the purified P126 was found to significantly reduce the listerial load in the liver and spleen and, further, that this reduction translated to reduced clinical signs of disease.

CONCLUSIONS:

This is the first report of a Class IIA bacteriocin displaying in vivo antimicrobial activity. Such a result provides preliminary evidence that this class of molecules may be useful in controlling systemic bacterial infections.

PMID:
12716771
DOI:
10.1093/jac/dkg229
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center